We are excited to welcome Richard Levenson, M.D. to further strengthen our leadership team as a member of the Board of Directors of Immunophotonics, Inc.

Dr. Levenson is a Professor of Pathology at UC Davis, internationally recognized for his pioneering work in medical imaging, cancer diagnostics, and translational research. His career spans academia and industry. His innovations in multispectral imaging, slide-free microscopy, and AI-powered pathology bridge academia and industry, earning honors such as UC Davis Chancellor’s Innovator of the Year and election as a SPIE Fellow.

Dr. Levenson’s expertise and strategic insight to our Board will help guide our scientific and strategic growth as we advance and deliver transformative immunotherapies.

Dr. Levenson’s connection to our mission is also personal: when his family cat, Gabriella, was diagnosed with a locally aggressive oral tumor and given one month to live, she was treated with our in situ autologous cancer vaccine (IP-001, formerly inCVAX). Gabriella received three treatments and remained disease-free more than three years later. Her recovery highlights the real-world impact of our technology across species.

Please join us in welcoming Dr. Levenson to our Board. We look forward to his insights and leadership as we advance innovative immunotherapies for cancer. Official Press Release